Fine Particle Exposure and Clinical Aggravation in Neurodegenerative Diseases in New York State
Open accessThe DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Adult-onset neurodegenerative diseases affect millions and negatively impact health care systems worldwide.Evidence suggests that air pollution may contribute to aggravation of neurodegeneration, but studies have been limited.OBJECTIVE: We examined the potential association between long-term exposure to particulate matter ≤2:5 lm in aerodynamic diameter [fine particulate matter (PM 2:5 )] and disease aggravation in Alzheimer's (AD) and Parkinson's (PD) diseases and amyotrophic lateral sclerosis (ALS), using first hospitalization as a surrogate of clinical aggravation.METHODS: We used data from the New York Department of Health Statewide Planning and Research Cooperative System (SPARCS 2000-2014) to construct annual county counts of first hospitalizations with a diagnosis of AD, PD, or ALS (total, urbanicity-, sex-, and age-stratified).We used annual PM 2:5 concentrations estimated by a prediction model at a 1-km 2 resolution, which we aggregated to population-weighted county averages to assign exposure to cases based on county of residence.We used outcome-specific mixed quasi-Poisson models with county-specific random intercepts to estimate rate ratios (RRs) for a 1-y PM 2:5 exposure.We allowed for nonlinear exposure-outcome relationships using penalized splines and accounted for potential confounders.RESULTS: We found a positive nonlinear PM 2:5 -PD association that plateaued above 11 lg=m 3 (RR = 1:09, 95% CI: 1.04, 1.14 for a PM 2:5 increase from 8.1 to 10:4 lg=m 3 ).We also found a linear PM 2:5 -ALS positive association (RR = 1:05, 95% CI: 1.01, 1.09 per 1-lg=m 3 PM 2:5 increase), and suggestive evidence of an association with AD.We found effect modification by age for PD and ALS with a stronger positive association in patients <70 years of age but found insufficient evidence of effect modification by sex or urbanization level for any of the outcomes.CONCLUSION: Our findings suggest that annual increase in county-level PM 2:5 concentrations may contribute to clinical aggravation of PD and ALS.Importantly, the average annual PM 2:5 concentration in our study was 8:1 lg=m 3 , below the current American national standards, suggesting the standards may not adequately protect the aging population.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The molecular pathology of Alzheimer's disease
Selkoe, D. J. (1991) · Neuron · doi:10.1016/0896-6273(91)90052-2 · Cited by 2,708
Stages in the development of Parkinson’s disease-related pathology
Braak, H., Ghebremedhin, E., Rüb, U., Bratzke, H., & Del Tredici, K. (2004) · Cell and Tissue Research · doi:10.1007/s00441-004-0956-9 · Cited by 2,689 · cited 1×
“…aerodynamic diameter [fine particulate matter (PM2:5)], with neuroinflammation, oxidative stress, and tau, amyloid, and a-synuclein proteinopathies (Calderón-Garcidueñas et al. 2004, 2008, 2010, 2012, 2016; Block and Calderón-Garcidueñas 2009; Jang et al. 2018; Cheng et al. 2016; Costa et al.…”
Background2019 Alzheimer’s disease facts and figures.
Alzheimer's Association (2019) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2019.01.010 · Cited by 2,461
How common are the "common" neurologic disorders?
Hirtz, D., Thurman, D. J., Gwinn-Hardy, K., Mohamed, M., Chaudhuri, A. R., & Zalutsky, R. (2007) · Neurology · doi:10.1212/01.wnl.0000252807.38124.a3 · Cited by 1,365
The Accuracy of Medicare Claims as an Epidemiological Tool: The Case of Dementia Revisited
Taylor, Jr., Østbye, T., Langa, K. M., Weir, D., & Plassman, B. L. (2009) · Journal of Alzheimer's Disease · doi:10.3233/jad-2009-1099 · Cited by 354
The epidemiology of amyotrophic lateral sclerosis
(2016) · Handbook of Clinical Neurology · doi:10.1016/b978-0-12-802973-2.00013-6 · Cited by 353 · cited 1×
“Amyotrophic lateral sclerosis (ALS) is an adult-onset rare motor neuron degenerative disorder with an annual global incidence of 1–2.6 cases per 100,000 people (Talbott et al. 2016; Hirtz et al. 2007).”
BackgroundInfluential
Cited by
Environmental pollution, a hidden culprit for health issues
Xu, H., Jia, Y., Sun, Z., Su, J., Liu, Q. S., Zhou, Q., & Jiang, G. (2022) · Eco-Environment & Health · doi:10.1016/j.eehl.2022.04.003 · Cited by 327
Shi, L., Steenland, K., Li, H., Liu, P., Zhang, Y., Lyles, R. H., Requia, W. J., Ilango, S. D., Chang, H. H., Wingo, T., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-27049-2 · Cited by 239
Ambient air pollution and clinical dementia: systematic review and meta-analysis
Wilker, E. H., Osman, M., & Weisskopf, M. G. (2023) · BMJ · doi:10.1136/bmj-2022-071620 · Cited by 186
Self-citationLetellier, N., Gutierrez, L., Duchesne, J., Chen, C., Ilango, S., Helmer, C., Berr, C., Mortamais, M., & Benmarhnia, T. (2022) · Alzheimer's & Dementia · doi:10.1002/alz.12606 · Cited by 23
Metadata
- Authors
- Nunez, Y., Boehme, A. K., Weisskopf, M. G., Re, D. B., Navas-Acien, A., van Donkelaar, A., Martin, R. V., & Kioumourtzoglou, M.-A.
- Venue
- Environmental Health Perspectives
- Publisher
- American Chemical Society (ACS)
- Published
- 2021-02
- Volume
- 129
- Issue
- 2
- Pages
- 27003-27003
- ISSN
- 0091-6765 (ISSN-L)
- 1552-9924
- OpenAlex
- W3127979955
- Cited by
- 53
- References
- 6
- FWCI
- 3.29
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Fine Particle Exposure and Clinical Aggravation in Neurodegenerative Diseases in New York State. https://app.cochat.ai/papers/10.1289/ehp7425
- The paper
- Nunez, Y., Boehme, A. K., Weisskopf, M. G., Re, D. B., Navas-Acien, A., van Donkelaar, A., Martin, R. V., & Kioumourtzoglou, M.-A. (2021). Fine Particle Exposure and Clinical Aggravation in Neurodegenerative Diseases in New York State. Environmental Health Perspectives. https://doi.org/10.1289/ehp7425
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.